Nearly 2.2 million patients were prescribed a GLP-1 RA between January 2019 and December 2025, according to the study.
Contunue read here.
Nearly 2.2 million patients were prescribed a GLP-1 RA between January 2019 and December 2025, according to the study.
Contunue read here.
